AMN Healthcare Services, Inc. Announces Shareholder Approval of Amendment No. 1 to the 2025 Equity Plan

Key Points:

• The Board of Directors of AMN Healthcare Services, Inc. (“AMN” or the “Company”) received shareholder approval for Amendment No. 1 to the AMN Healthcare 2025 Equity Plan at its Annual Meeting held on May 1, 2026.
• The amendment increases the number of shares issuable under the plan by 1,420,000 shares, raising the aggregate authorized shares for awards under the plan to 2,258,714 shares.
• Clarifications were made to the plan regarding the add-back of certain shares and director limits.
• The amendment is effective as of shareholder approval and will be void if not approved by shareholders.
• All other provisions of the plan remain unchanged.

Shareholder and Investor Impact:

• Increase in Share Authorization: The addition of 1,420,000 shares available for equity awards could have a significant impact on AMN’s future equity compensation practices. This increase may lead to further dilution for existing shareholders if new awards are granted.
• Potential Share Price Sensitivity: Expanding the equity plan enables AMN to issue more shares to employees, directors, and other eligible participants. This is generally viewed as a move to incentivize key talent and align interests, but it also introduces the risk of share dilution.
• Director Limits and Add-back Clarifications: The amendment removes ambiguous language about add-backs for Stock Appreciation Rights and director limits, providing greater clarity and compliance in plan administration.
• Corporate Governance and Transparency: Shareholders approved these changes at the Annual Meeting, indicating support for the company’s ongoing equity incentive strategies.
• Price-sensitive Information: Shareholders and potential investors should note that the expanded pool for awards could lead to greater dilution if the company issues new grants, and may impact earnings per share (EPS) calculations in the future.

Other Annual Meeting Results:

• Approval of executive compensation (advisory basis).
• Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
• Election of directors and other routine matters.

Summary of Amendment No. 1:

• Section 3(a): Amended to state that 2,258,714 shares in aggregate are authorized for awards, minus shares granted after March 3, 2026. No more than 1,000,000 shares may be granted as Incentive Stock Options.
• Section 3(b): Deletes specific language about add-back of shares in payment for Stock Appreciation Rights.
• Section 3(d): Deletes the last sentence, clarifying director limits.
• Full Force and Effect: Except as amended, all provisions of the plan remain in effect.
• Effective Date: The amendment is effective upon shareholder approval and is void if not approved.

Important for Shareholders:

• The increase in shares authorized for equity awards is a material development, potentially impacting share value through dilution and future compensation practices.
• Investors should monitor how AMN utilizes its increased equity award capacity, as aggressive issuance may affect share price and EPS.
• The amendment is now in effect and will shape future equity compensation and governance at AMN Healthcare Services.

Disclaimer: This article is based on publicly filed information and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own research and consult with qualified financial advisors before making any investment decisions. The author and publisher are not responsible for any actions taken based on this article.

View AMN HEALTHCARE SERVICES INC Historical chart here